{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:35:44Z","timestamp":1769859344804,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"DOI":"10.1007\/s00784-023-05462-9","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T10:02:12Z","timestamp":1703671332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is withdrawal of antiresorptive agents necessary before and after tooth extraction? A systematic review"],"prefix":"10.1007","volume":"28","author":[{"given":"Daisuke","family":"Takeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Soutome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"key":"5462_CR1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117. https:\/\/doi.org\/10.1016\/s0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"key":"5462_CR2","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72:1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"5462_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","volume":"35","author":"T Yoneda","year":"2017","unstructured":"Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Nagata T, Urade M, Shibahara T, Toyosawa S (2017) Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab 35:6\u201319. https:\/\/doi.org\/10.1007\/s00774-016-0810-7","journal-title":"J Bone Miner Metab"},{"key":"5462_CR4","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/jco.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, Murphy BA, Alston-Johnson D, Mendes RA, Beadle BM, Jensen SB, Saunders DP (2019) Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline. J Clin Oncol 37:2270\u20132290. https:\/\/doi.org\/10.1200\/jco.19.01186","journal-title":"J Clin Oncol"},{"key":"5462_CR5","doi-asserted-by":"publisher","unstructured":"Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G, Consolo U, Di Fede O, Favia G, Fusco V, Gabriele M, Lo Casto A, Lo Muzio L, Marcian\u00f2 A, Mascitti M, Meleti M, Mignogna MD, Oteri G, Panzarella V, Romeo U, Santarelli A, Vescovi P, Marchetti C and Bedogni A (2020) Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. Int J Environ Res Public Health 17. https:\/\/doi.org\/10.3390\/ijerph17165998","DOI":"10.3390\/ijerph17165998"},{"key":"5462_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.11005\/jbm.2021.28.4.279","volume":"28","author":"JW Kim","year":"2021","unstructured":"Kim JW, Kwak MK, Han JJ, Lee ST, Kim HY, Kim SH, Jung J, Lee JK, Lee YK, Kwon YD, Kim DY (2021) Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab 28:279\u2013296. https:\/\/doi.org\/10.11005\/jbm.2021.28.4.279","journal-title":"J Bone Metab"},{"key":"5462_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/clinem\/dgab888","volume":"107","author":"AD Anastasilakis","year":"2022","unstructured":"Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ (2022) Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS. J Clin Endocrinol Metab 107:1441\u20131460. https:\/\/doi.org\/10.1210\/clinem\/dgab888","journal-title":"J Clin Endocrinol Metab"},{"key":"5462_CR8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.joms.2021.12.007","volume":"80","author":"M Ishimaru","year":"2022","unstructured":"Ishimaru M, Ono S, Morita K, Matsui H, Hagiwara Y, Yasunaga H (2022) Prevalence, incidence rate, and risk factors of medication-related osteonecrosis of the jaw in patients with osteoporosis and cancer: a nationwide population-based study in Japan. J Oral Maxillofac Surg 80:714\u2013727. https:\/\/doi.org\/10.1016\/j.joms.2021.12.007","journal-title":"J Oral Maxillofac Surg"},{"key":"5462_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","volume":"16","author":"RA Miksad","year":"2011","unstructured":"Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS (2011) Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16:121\u2013132. https:\/\/doi.org\/10.1634\/theoncologist.2010-0183","journal-title":"Oncologist"},{"key":"5462_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.oooo.2020.03.051","volume":"130","author":"T Sato","year":"2020","unstructured":"Sato T, Kusumoto J, Takeda D, Kishimoto M, Kashin M, Furudoi S, Akashi M (2020) Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw? Oral Surg Oral Med Oral Pathol Oral Radiol 130:175\u2013180. https:\/\/doi.org\/10.1016\/j.oooo.2020.03.051","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"5462_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"5462_CR12","doi-asserted-by":"publisher","first-page":"Cd012432","DOI":"10.1002\/14651858.CD012432.pub2","volume":"10","author":"NH Beth-Tasdogan","year":"2017","unstructured":"Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O (2017) Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev 10:Cd012432. https:\/\/doi.org\/10.1002\/14651858.CD012432.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"5462_CR13","doi-asserted-by":"publisher","first-page":"Cd008455","DOI":"10.1002\/14651858.CD008455.pub2","volume":"2","author":"V Rollason","year":"2016","unstructured":"Rollason V, Laverri\u00e8re A, MacDonald LC, Walsh T, Tram\u00e8r MR, Vogt-Ferrier NB (2016) Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Cochrane Database Syst Rev 2:Cd008455. https:\/\/doi.org\/10.1002\/14651858.CD008455.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"5462_CR14","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"5462_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW Jr, Atkins D, Meerpohl J, Sch\u00fcnemann HJ (2011) GRADE guidelines: 4. Rating the quality of evidence\u2013study limitations (risk of bias). J Clin Epidemiol 64:407\u2013415. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.017","journal-title":"J Clin Epidemiol"},{"key":"5462_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ajoms.2017.07.008","volume":"29","author":"A Kawakita","year":"2017","unstructured":"Kawakita A, Yanamoto S, Morishita K, Naruse T, Hayashida S, Soutome S, Rokutanda S, Inokuchi S, Matsuo T, Umeda M (2017) Discontinuing oral bisphosphonate therapy during dental extraction does not prevent osteonecrosis of the jaw: a multicenter retrospective study of 341 patients with propensity score matching analysis. J Oral Maxillofacial Surg, Med Pathol 29:522\u2013526","journal-title":"J Oral Maxillofacial Surg, Med Pathol"},{"key":"5462_CR17","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","volume":"28","author":"T Hasegawa","year":"2017","unstructured":"Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S, Yanamoto S, Komatsubara H, Umeda M, Kirita T, Kurita H, Shibuya Y, Komori T (2017) A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int 28:2465\u20132473. https:\/\/doi.org\/10.1007\/s00198-017-4063-7","journal-title":"Osteoporos Int"},{"key":"5462_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00198-013-2437-z","volume":"25","author":"A Neuprez","year":"2014","unstructured":"Neuprez A, Coste S, Rompen E, Crielaard JM, Reginster JY (2014) Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab. Osteoporos Int 25:393\u2013395. https:\/\/doi.org\/10.1007\/s00198-013-2437-z","journal-title":"Osteoporos Int"},{"key":"5462_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.12968\/denu.2014.41.5.449","volume":"41","author":"S Vyas","year":"2014","unstructured":"Vyas S, Hameed S, Murugaraj V (2014) Denosumab-associated osteonecrosis of the jaw\u2013a case report. Dent Update 41:449\u201350. https:\/\/doi.org\/10.12968\/denu.2014.41.5.449","journal-title":"Dent Update"},{"key":"5462_CR20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00198-017-4334-3","volume":"29","author":"R Niimi","year":"2018","unstructured":"Niimi R, Kono T, Nishihara A, Hasegawa M, Kono T, Sudo A (2018) Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis. Osteoporos Int 29:769\u2013772. https:\/\/doi.org\/10.1007\/s00198-017-4334-3","journal-title":"Osteoporos Int"},{"key":"5462_CR21","doi-asserted-by":"publisher","first-page":"e03795","DOI":"10.1016\/j.heliyon.2020.e03795","volume":"6","author":"C Ottesen","year":"2020","unstructured":"Ottesen C, Schiodt M, Gotfredsen K (2020) Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon 6:e03795. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03795","journal-title":"Heliyon"},{"key":"5462_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.oooo.2021.06.003","volume":"133","author":"C Ottesen","year":"2022","unstructured":"Ottesen C, Schiodt M, Jensen SS, Kofod T, Gotfredsen K (2022) Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation. Oral Surg Oral Med Oral Pathol Oral Radiol 133:165\u2013173. https:\/\/doi.org\/10.1016\/j.oooo.2021.06.003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"5462_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jcms.2015.02.018","volume":"43","author":"JP Bodem","year":"2015","unstructured":"Bodem JP, Kargus S, Eckstein S, Saure D, Engel M, Hoffmann J, Freudlsperger C (2015) Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction. J Craniomaxillofac Surg 43:510\u2013514. https:\/\/doi.org\/10.1016\/j.jcms.2015.02.018","journal-title":"J Craniomaxillofac Surg"},{"key":"5462_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00198-018-4746-8","volume":"30","author":"T Hasegawa","year":"2019","unstructured":"Hasegawa T, Hayashida S, Kondo E, Takeda Y, Miyamoto H, Kawaoka Y, Ueda N, Iwata E, Nakahara H, Kobayashi M, Soutome S, Yamada SI, Tojyo I, Kojima Y, Umeda M, Fujita S, Kurita H, Shibuya Y, Kirita T, Komori T (2019) Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study. Osteoporos Int 30:231\u2013239. https:\/\/doi.org\/10.1007\/s00198-018-4746-8","journal-title":"Osteoporos Int"},{"key":"5462_CR25","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00198-021-05995-3","volume":"32","author":"T Hasegawa","year":"2021","unstructured":"Hasegawa T, Ueda N, Yamada SI, Kato S, Iwata E, Hayashida S, Kojima Y, Shinohara M, Tojo I, Nakahara H, Yamaguchi T, Kirita T, Kurita H, Shibuya Y, Soutome S, Akashi M (2021) Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study. Osteoporos Int 32:2323\u20132333. https:\/\/doi.org\/10.1007\/s00198-021-05995-3","journal-title":"Osteoporos Int"},{"key":"5462_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg 80:920\u2013943. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"5462_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jcpe.12455","volume":"42","author":"E Gaudin","year":"2015","unstructured":"Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F (2015) Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol 42:922\u2013932. https:\/\/doi.org\/10.1111\/jcpe.12455","journal-title":"J Clin Periodontol"},{"key":"5462_CR28","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s00198-019-05002-w","volume":"30","author":"EM Dennison","year":"2019","unstructured":"Dennison EM, Cooper C, Kanis JA, Bruy\u00e8re O, Silverman S, McCloskey E, Abrahamsen B, Prieto-Alhambra D, Ferrari S (2019) Fracture risk following intermission of osteoporosis therapy. Osteoporos Int 30:1733\u20131743. https:\/\/doi.org\/10.1007\/s00198-019-05002-w","journal-title":"Osteoporos Int"},{"key":"5462_CR29","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s40265-021-01587-x","volume":"81","author":"LPB Elbers","year":"2021","unstructured":"Elbers LPB, Raterman HG, Lems WF (2021) Bone mineral density loss and fracture risk after discontinuation of anti-osteoporotic drug treatment: a narrative review. Drugs 81:1645\u20131655. https:\/\/doi.org\/10.1007\/s40265-021-01587-x","journal-title":"Drugs"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-023-05462-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-023-05462-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-023-05462-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T08:10:10Z","timestamp":1707379810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-023-05462-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["5462"],"URL":"https:\/\/doi.org\/10.1007\/s00784-023-05462-9","relation":{},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,27]]},"assertion":[{"value":"25 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"38"}}